BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 31009074)

  • 1. α-synuclein oligomers enhance astrocyte-induced synapse formation through TGF-β1 signaling in a Parkinson's disease model.
    Diniz LP; Matias I; Araujo APB; Garcia MN; Barros-Aragão FGQ; Alves-Leon SV; de Souza JM; Foguel D; Figueiredo CP; Braga C; Romão L; Gomes FCA
    J Neurochem; 2019 Jul; 150(2):138-157. PubMed ID: 31009074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astrocyte Transforming Growth Factor Beta 1 Protects Synapses against Aβ Oligomers in Alzheimer's Disease Model.
    Diniz LP; Tortelli V; Matias I; Morgado J; Bérgamo Araujo AP; Melo HM; Seixas da Silva GS; Alves-Leon SV; de Souza JM; Ferreira ST; De Felice FG; Gomes FCA
    J Neurosci; 2017 Jul; 37(28):6797-6809. PubMed ID: 28607171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astrocyte glutamate transporters are increased in an early sporadic model of synucleinopathy.
    Diniz LP; Araujo APB; Matias I; Garcia MN; Barros-Aragão FGQ; de Melo Reis RA; Foguel D; Braga C; Figueiredo CP; Romão L; Gomes FCA
    Neurochem Int; 2020 Sep; 138():104758. PubMed ID: 32439533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astrocyte transforming growth factor beta 1 promotes inhibitory synapse formation via CaM kinase II signaling.
    Diniz LP; Tortelli V; Garcia MN; Araújo AP; Melo HM; Silva GS; Felice FG; Alves-Leon SV; Souza JM; Romão LF; Castro NG; Gomes FC
    Glia; 2014 Dec; 62(12):1917-31. PubMed ID: 25042347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson's disease and does not lead to a sustainable increase of brain-derived neurotrophic factor.
    Komnig D; Dagli TC; Habib P; Zeyen T; Schulz JB; Falkenburger BH
    J Neurochem; 2018 Dec; 147(5):678-691. PubMed ID: 30152864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aquaporin-4 deficiency reduces TGF-β1 in mouse midbrains and exacerbates pathology in experimental Parkinson's disease.
    Xue X; Zhang W; Zhu J; Chen X; Zhou S; Xu Z; Hu G; Su C
    J Cell Mol Med; 2019 Apr; 23(4):2568-2582. PubMed ID: 30680924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astrocyte support is important for the compensatory potential of the nigrostriatal system neurons during early neurodegeneration.
    Kuter K; Olech Ł; Głowacka U; Paleczna M
    J Neurochem; 2019 Jan; 148(1):63-79. PubMed ID: 30295916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine and α-synuclein dysfunction in Smad3 null mice.
    Tapia-González S; Giráldez-Pérez RM; Cuartero MI; Casarejos MJ; Mena MÁ; Wang XF; Sánchez-Capelo A
    Mol Neurodegener; 2011 Oct; 6():72. PubMed ID: 21995845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamate activates GFAP gene promoter from cultured astrocytes through TGF-beta1 pathways.
    Romão LF; Sousa Vde O; Neto VM; Gomes FC
    J Neurochem; 2008 Jul; 106(2):746-56. PubMed ID: 18419760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss.
    Trudler D; Sanz-Blasco S; Eisele YS; Ghatak S; Bodhinathan K; Akhtar MW; Lynch WP; Piña-Crespo JC; Talantova M; Kelly JW; Lipton SA
    J Neurosci; 2021 Mar; 41(10):2264-2273. PubMed ID: 33483428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta1/SMAD signaling induces astrocyte fate commitment in vitro: implications for radial glia development.
    Stipursky J; Gomes FC
    Glia; 2007 Aug; 55(10):1023-33. PubMed ID: 17549683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC α-synuclein transgenic rat model of Parkinson's disease.
    Kohl Z; Ben Abdallah N; Vogelgsang J; Tischer L; Deusser J; Amato D; Anderson S; Müller CP; Riess O; Masliah E; Nuber S; Winkler J
    Neurobiol Dis; 2016 Jan; 85():206-217. PubMed ID: 26523794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocyte-induced synaptogenesis is mediated by transforming growth factor β signaling through modulation of D-serine levels in cerebral cortex neurons.
    Diniz LP; Almeida JC; Tortelli V; Vargas Lopes C; Setti-Perdigão P; Stipursky J; Kahn SA; Romão LF; de Miranda J; Alves-Leon SV; de Souza JM; Castro NG; Panizzutti R; Gomes FC
    J Biol Chem; 2012 Nov; 287(49):41432-45. PubMed ID: 23055518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Synuclein oligomers potentiate neuroinflammatory NF-κB activity and induce Ca
    Leandrou E; Chalatsa I; Anagnostou D; Machalia C; Semitekolou M; Filippa V; Makridakis M; Vlahou A; Anastasiadou E; Vekrellis K; Emmanouilidou E
    Transl Neurodegener; 2024 Feb; 13(1):11. PubMed ID: 38378800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuron-glia signaling: Implications for astrocyte differentiation and synapse formation.
    Stipursky J; Romão L; Tortelli V; Neto VM; Gomes FC
    Life Sci; 2011 Oct; 89(15-16):524-31. PubMed ID: 21569780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The histone deacetylase inhibitor nicotinamide exacerbates neurodegeneration in the lactacystin rat model of Parkinson's disease.
    Harrison IF; Powell NM; Dexter DT
    J Neurochem; 2019 Jan; 148(1):136-156. PubMed ID: 30269333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
    Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
    Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocyte inflammatory signaling mediates α-synuclein aggregation and dopaminergic neuronal loss following viral encephalitis.
    Bantle CM; Rocha SM; French CT; Phillips AT; Tran K; Olson KE; Bass TA; Aboellail T; Smeyne RJ; Tjalkens RB
    Exp Neurol; 2021 Dec; 346():113845. PubMed ID: 34454938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-β1 Neuroprotection via Inhibition of Microglial Activation in a Rat Model of Parkinson's Disease.
    Chen X; Liu Z; Cao BB; Qiu YH; Peng YP
    J Neuroimmune Pharmacol; 2017 Sep; 12(3):433-446. PubMed ID: 28429275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid oligomerization of the Parkinson's disease related protein α-synuclein impacts on its curvature-membrane sensitivity.
    Gallea JI; Ambroggio EE; Vilcaes AA; James NG; Jameson DM; Celej MS
    J Neurochem; 2018 Nov; 147(4):541-556. PubMed ID: 30142705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.